Skip to main content
Erschienen in: Journal of Neural Transmission 1/2015

01.08.2015 | Neurology and Preclinical Neurological Studies - Review Article

Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle

verfasst von: A. Popa-Wagner, Ana-Maria Buga, B. Popescu, D. Muresanu

Erschienen in: Journal of Neural Transmission | Sonderheft 1/2015

Einloggen, um Zugang zu erhalten

Abstract

To a great extent, cognitive health depends on cerebrovascular health and a deeper understanding of the subtle interactions between cerebrovascular function and cognition is needed to protect humans from one of the most devastating affliction, dementia. However, the underlying biological mechanisms are still not completely clear. Many studies demonstrated that the neurovascular unit is compromised in cerebrovascular diseases and also in other types of dementia. The hemodynamic neurovascular coupling ensures a strong increase of the cerebral blood flow (CBF) and an acute increase in neuronal glucose uptake upon increased neural activity. Dysfunction of cerebral autoregulation with increasing age along with age-related structural and functional alterations in cerebral blood vessels including accumulation of amyloid-beta (Aβ) in the media of cortical arterioles, neurovascular uncoupling due to astrocyte endfeet retraction, impairs the CBF and increases the neuronal degeneration and susceptibility to hypoxia and ischemia. A decreased cerebral glucose metabolism is an early event in Alzheimer’s disease (AD) pathology and may precede the neuropathological Aβ deposition associated with AD. Aβ accumulation in turn leads to further decreases in the CBF closing the vicious cycle. Alzheimer, aging and diabetes are also influenced by insulin/insulin-like growth factor-1 signaling, and accumulated evidence indicates sporadic AD is associated with disturbed brain insulin metabolism. Understanding how vascular and metabolic factors interfere with progressive loss of functional neuronal networks becomes essential to develop efficient drugs to prevent cognitive decline in elderly.
Literatur
Zurück zum Zitat Aichner F, Bauer G (2005) Cerebral anoxia. In: Niedermeyer E, Lopez da Silva F (eds) Electroencephalography: basic principles, clinical applications and related fields, Williams & Wilkins, Baltimore, pp 455–470 Aichner F, Bauer G (2005) Cerebral anoxia. In: Niedermeyer E, Lopez da Silva F (eds) Electroencephalography: basic principles, clinical applications and related fields, Williams & Wilkins, Baltimore, pp 455–470
Zurück zum Zitat Baquer NZ, Taha A, Kumar P et al (2009) A metabolic and functional overview of brain aging linked to neurological disorders. Biogerontology 10:377–413PubMedCrossRef Baquer NZ, Taha A, Kumar P et al (2009) A metabolic and functional overview of brain aging linked to neurological disorders. Biogerontology 10:377–413PubMedCrossRef
Zurück zum Zitat Barone FC, Rosenbaum DM, Zhou J et al (2009) Vascular cognitive impairment: dementia biology and translational animal models. Curr Opin Investig Drugs 10:624–637PubMed Barone FC, Rosenbaum DM, Zhou J et al (2009) Vascular cognitive impairment: dementia biology and translational animal models. Curr Opin Investig Drugs 10:624–637PubMed
Zurück zum Zitat Biagi L, Abbruzzese A, Bianchi MC et al (2007) Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. Magn Reson Imaging 25:696–702CrossRef Biagi L, Abbruzzese A, Bianchi MC et al (2007) Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. Magn Reson Imaging 25:696–702CrossRef
Zurück zum Zitat Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74PubMedCrossRef Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74PubMedCrossRef
Zurück zum Zitat Breteler MM (2000) Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol Aging 21:153–160PubMedCrossRef Breteler MM (2000) Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol Aging 21:153–160PubMedCrossRef
Zurück zum Zitat Chen Z, Zhong C (2013) Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21–43PubMedCrossRef Chen Z, Zhong C (2013) Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21–43PubMedCrossRef
Zurück zum Zitat Chen W, Novotny EJ, Zhu X, Rothman DL, Shulman RG (1993) Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc Natl Acad Sci USA 90:9896–9900PubMedCentralPubMedCrossRef Chen W, Novotny EJ, Zhu X, Rothman DL, Shulman RG (1993) Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc Natl Acad Sci USA 90:9896–9900PubMedCentralPubMedCrossRef
Zurück zum Zitat Chua LM, Lim ML, Chong PR, Hu ZP, Cheung NS, Wong BS (2012) Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice. J Alzheimers Dis 29:783–791PubMed Chua LM, Lim ML, Chong PR, Hu ZP, Cheung NS, Wong BS (2012) Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice. J Alzheimers Dis 29:783–791PubMed
Zurück zum Zitat Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10:264–273PubMedCentralPubMedCrossRef Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10:264–273PubMedCentralPubMedCrossRef
Zurück zum Zitat de la Torre JC, Mussivand T (1993) Can disturbed brain microcirculation cause Alzheimer’s disease? Neurol Res 15:146–153PubMed de la Torre JC, Mussivand T (1993) Can disturbed brain microcirculation cause Alzheimer’s disease? Neurol Res 15:146–153PubMed
Zurück zum Zitat den Dunnen WF, Brouwer WH, Bijlard E et al (2008) No disease in the brain of a 115-year-old woman. Neurobiol Aging 29:1127–1132CrossRef den Dunnen WF, Brouwer WH, Bijlard E et al (2008) No disease in the brain of a 115-year-old woman. Neurobiol Aging 29:1127–1132CrossRef
Zurück zum Zitat Desmond DW, Moroney JT, Sano M et al (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33:2254–2260PubMedCrossRef Desmond DW, Moroney JT, Sano M et al (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33:2254–2260PubMedCrossRef
Zurück zum Zitat Dugan LL, Kim-Han JS (2006) Hypoxic-ischemic brain injury and oxidative stress. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry: molecular, cellular and medical aspects. Elsevier, AP, pp 559–573 Dugan LL, Kim-Han JS (2006) Hypoxic-ischemic brain injury and oxidative stress. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry: molecular, cellular and medical aspects. Elsevier, AP, pp 559–573
Zurück zum Zitat Emmanuel Y, Cochlin LE, Tyler DJ, de Jager CA, David Smith A, Clarke K (2013) Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance. Brain Behav 3:134–144PubMedCentralPubMedCrossRef Emmanuel Y, Cochlin LE, Tyler DJ, de Jager CA, David Smith A, Clarke K (2013) Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance. Brain Behav 3:134–144PubMedCentralPubMedCrossRef
Zurück zum Zitat Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. Nat Rev Neurol 5:649–658PubMedCrossRef Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. Nat Rev Neurol 5:649–658PubMedCrossRef
Zurück zum Zitat Games D, Buttini M, Kobayashi D, Schenk D, Seubert P (2006) Mice as models: transgenic approaches and Alzheimer’s disease. J Alzheimers Dis 9:133–149PubMed Games D, Buttini M, Kobayashi D, Schenk D, Seubert P (2006) Mice as models: transgenic approaches and Alzheimer’s disease. J Alzheimers Dis 9:133–149PubMed
Zurück zum Zitat Giménez-Llort L, Blázquez G, Cañete T, Johansson B et al (2007) Modeling behavioral and neuronal symptoms of Alzheimer’s disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 31:125–147PubMedCrossRef Giménez-Llort L, Blázquez G, Cañete T, Johansson B et al (2007) Modeling behavioral and neuronal symptoms of Alzheimer’s disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 31:125–147PubMedCrossRef
Zurück zum Zitat Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/American stroke association. Stroke 42:2672–713 Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/American stroke association. Stroke 42:2672–713
Zurück zum Zitat Grau-Olivares M, Arboix A (2009) Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother 9:1201–1217PubMedCrossRef Grau-Olivares M, Arboix A (2009) Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother 9:1201–1217PubMedCrossRef
Zurück zum Zitat Hachinski VC, Lassen NA, Marshall J (1974) Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 2:207–210PubMedCrossRef Hachinski VC, Lassen NA, Marshall J (1974) Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 2:207–210PubMedCrossRef
Zurück zum Zitat Hachinski V, Iadecola C, Petersen RC et al (2006) National institute of neurological disorders and stroke-Canadian stroke network vascular cognitive impairment harmonization standards. Stroke 37:2220–2241PubMedCrossRef Hachinski V, Iadecola C, Petersen RC et al (2006) National institute of neurological disorders and stroke-Canadian stroke network vascular cognitive impairment harmonization standards. Stroke 37:2220–2241PubMedCrossRef
Zurück zum Zitat Henneberg N, Hoyer S (1995) Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 21:63–74PubMedCrossRef Henneberg N, Hoyer S (1995) Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 21:63–74PubMedCrossRef
Zurück zum Zitat Hermann DM, Chopp M (2012) Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 11:369–380PubMedCentralPubMedCrossRef Hermann DM, Chopp M (2012) Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 11:369–380PubMedCentralPubMedCrossRef
Zurück zum Zitat Hoyer S (1991) Abnormalities of glucose metabolism in Alzheimer’s disease. Ann NY Acad Sci 640:53–58PubMed Hoyer S (1991) Abnormalities of glucose metabolism in Alzheimer’s disease. Ann NY Acad Sci 640:53–58PubMed
Zurück zum Zitat Hoyer S (2002) The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109:341–360PubMedCrossRef Hoyer S (2002) The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109:341–360PubMedCrossRef
Zurück zum Zitat Hoyer S, Lannert H, Latteier E, Meisel T (2004) Relationship between cerebral energy metabolism in parietotemporal cortex and hippocampus and mental activity during aging in rats. J Neural Transm 111:575–589PubMedCrossRef Hoyer S, Lannert H, Latteier E, Meisel T (2004) Relationship between cerebral energy metabolism in parietotemporal cortex and hippocampus and mental activity during aging in rats. J Neural Transm 111:575–589PubMedCrossRef
Zurück zum Zitat Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 5:347–360PubMedCrossRef Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 5:347–360PubMedCrossRef
Zurück zum Zitat Iadecola C, Gorelick PB (2003) Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 34:335–337PubMedCrossRef Iadecola C, Gorelick PB (2003) Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 34:335–337PubMedCrossRef
Zurück zum Zitat Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral microvasculature. Nat Neurosci 10:1369–1376PubMedCrossRef Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral microvasculature. Nat Neurosci 10:1369–1376PubMedCrossRef
Zurück zum Zitat Itoh Y, Yamada M, Hayakawa M et al (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116:135–141PubMedCrossRef Itoh Y, Yamada M, Hayakawa M et al (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116:135–141PubMedCrossRef
Zurück zum Zitat Jellinger KA (2002) Vascular-ischemic dementia: an update. J Neural Transm (Suppl) 62:1–23CrossRef Jellinger KA (2002) Vascular-ischemic dementia: an update. J Neural Transm (Suppl) 62:1–23CrossRef
Zurück zum Zitat Jellinger KA, Attems J (2010) Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol 119:421–433PubMedCrossRef Jellinger KA, Attems J (2010) Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol 119:421–433PubMedCrossRef
Zurück zum Zitat Jin F, Hagemann N, Schäfer ST et al (2013) SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradation. Cardiovasc Res 100:481–491PubMedCrossRef Jin F, Hagemann N, Schäfer ST et al (2013) SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradation. Cardiovasc Res 100:481–491PubMedCrossRef
Zurück zum Zitat Kamino K, Orr HT, Payami H et al (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 51:998–1014PubMedCentralPubMed Kamino K, Orr HT, Payami H et al (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 51:998–1014PubMedCentralPubMed
Zurück zum Zitat Laurent S, Briet M, Boutouyrie P (2009) Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension 54:388–392PubMedCrossRef Laurent S, Briet M, Boutouyrie P (2009) Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. Hypertension 54:388–392PubMedCrossRef
Zurück zum Zitat Li ZG, Zhang W, Sima AA (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56:1817–1824PubMedCrossRef Li ZG, Zhang W, Sima AA (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56:1817–1824PubMedCrossRef
Zurück zum Zitat Marini C, Totaro R, De Santis F et al (2001) Stroke in young adults in the community-based L’Aquila registry: incidence and prognosis. Stroke 32:52–56PubMedCrossRef Marini C, Totaro R, De Santis F et al (2001) Stroke in young adults in the community-based L’Aquila registry: incidence and prognosis. Stroke 32:52–56PubMedCrossRef
Zurück zum Zitat McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546–553PubMedCentralPubMedCrossRef McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546–553PubMedCentralPubMedCrossRef
Zurück zum Zitat Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM (2011) Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol 122:293–311PubMedCentralPubMedCrossRef Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM (2011) Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol 122:293–311PubMedCentralPubMedCrossRef
Zurück zum Zitat Meyer-Luehmann M, Coomaraswamy J, Bolmont T et al (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781–1784PubMedCrossRef Meyer-Luehmann M, Coomaraswamy J, Bolmont T et al (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781–1784PubMedCrossRef
Zurück zum Zitat Miravalle L, Tokuda T, Chiarle R et al (2000) Substitutions at codon 22 of Alzheimer’s abeta peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells. J Biol Chem 275:27110–27116PubMed Miravalle L, Tokuda T, Chiarle R et al (2000) Substitutions at codon 22 of Alzheimer’s abeta peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells. J Biol Chem 275:27110–27116PubMed
Zurück zum Zitat Mosconi L, Tsui WH, De Santi S et al (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64:1860–1867PubMedCrossRef Mosconi L, Tsui WH, De Santi S et al (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64:1860–1867PubMedCrossRef
Zurück zum Zitat Nagy Z, Esiri MM, Jobst KA et al (1997) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56:165–170PubMedCrossRef Nagy Z, Esiri MM, Jobst KA et al (1997) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56:165–170PubMedCrossRef
Zurück zum Zitat Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D Jr (2012) ApoE: the link between Alzheimer’s-related glucose hypometabolism and Aβ deposition? Med Hypotheses 78:494–496PubMedCrossRef Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D Jr (2012) ApoE: the link between Alzheimer’s-related glucose hypometabolism and Aβ deposition? Med Hypotheses 78:494–496PubMedCrossRef
Zurück zum Zitat Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D (2010) Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab 30:2–14PubMedCentralPubMedCrossRef Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D (2010) Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab 30:2–14PubMedCentralPubMedCrossRef
Zurück zum Zitat Pluta R, Jolkkonen J, Cuzzocrea S, Pedata F, Cechetto D, Popa-Wagner A (2011) Cognitive impairment with vascular impairment and degeneration. Curr Neurovasc Res. 8:342–350PubMedCrossRef Pluta R, Jolkkonen J, Cuzzocrea S, Pedata F, Cechetto D, Popa-Wagner A (2011) Cognitive impairment with vascular impairment and degeneration. Curr Neurovasc Res. 8:342–350PubMedCrossRef
Zurück zum Zitat Popa-Wagner A, Schroeder E, Walker LC, Kessler Ch (1998) ß-amyloid precursor protein and Aß peptide immunoreactivity in the rat brain following middle cerebral artery occlusion: effect of age. Stroke 29:2196–2202PubMedCrossRef Popa-Wagner A, Schroeder E, Walker LC, Kessler Ch (1998) ß-amyloid precursor protein and Aß peptide immunoreactivity in the rat brain following middle cerebral artery occlusion: effect of age. Stroke 29:2196–2202PubMedCrossRef
Zurück zum Zitat Popa-Wagner A, Pirici D, Zagrean AM et al (2010) Cerebral circulation: anatomy, distribution and physiopathology, advances in medicine and biology. pp 1–45 Popa-Wagner A, Pirici D, Zagrean AM et al (2010) Cerebral circulation: anatomy, distribution and physiopathology, advances in medicine and biology. pp 1–45
Zurück zum Zitat Price JM, Chi X, Hellermann G, Sutton ET (2001) Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res 23:506–512PubMedCrossRef Price JM, Chi X, Hellermann G, Sutton ET (2001) Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res 23:506–512PubMedCrossRef
Zurück zum Zitat Rensink AA, de Waal RM, Kremer B et al (2003) Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 43:207–223PubMedCrossRef Rensink AA, de Waal RM, Kremer B et al (2003) Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 43:207–223PubMedCrossRef
Zurück zum Zitat Roman GC, Tatemichi TK, Erkinjuntti T et al (1993) Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology 43:250–260PubMedCrossRef Roman GC, Tatemichi TK, Erkinjuntti T et al (1993) Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology 43:250–260PubMedCrossRef
Zurück zum Zitat Sadowski M, Pankiewicz J, Scholtzova H et al (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. Neuropathol Exp Neurol 63:418–428 Sadowski M, Pankiewicz J, Scholtzova H et al (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. Neuropathol Exp Neurol 63:418–428
Zurück zum Zitat Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62:1148–1155PubMedCrossRef Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62:1148–1155PubMedCrossRef
Zurück zum Zitat Selnes OA, Vinters HV (2006) Vascular cognitive impairment. Nat Clin Pract Neurol 2:538–534 Selnes OA, Vinters HV (2006) Vascular cognitive impairment. Nat Clin Pract Neurol 2:538–534
Zurück zum Zitat Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain. Brain Res Brain Res Rev 33:199–227PubMedCrossRef Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain. Brain Res Brain Res Rev 33:199–227PubMedCrossRef
Zurück zum Zitat Takeda S, Sato N, Rakugi H, Morishita R (2011) Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol BioSyst 7:1822–1827PubMedCrossRef Takeda S, Sato N, Rakugi H, Morishita R (2011) Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol BioSyst 7:1822–1827PubMedCrossRef
Zurück zum Zitat Talbot K, Wang HY, Kazi H et al (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338PubMedCentralPubMedCrossRef Talbot K, Wang HY, Kazi H et al (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338PubMedCentralPubMedCrossRef
Zurück zum Zitat Thal DR, Ghebremedhin E, Orantes M et al (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287–1301PubMed Thal DR, Ghebremedhin E, Orantes M et al (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287–1301PubMed
Zurück zum Zitat van Beek AH, Claassen JA, Rikkert MG, Jansen RW (2008) Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab 28:1071–1085PubMedCrossRef van Beek AH, Claassen JA, Rikkert MG, Jansen RW (2008) Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab 28:1071–1085PubMedCrossRef
Zurück zum Zitat Vinters HV, Ellis WG, Zarow C et al (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59:931–945PubMed Vinters HV, Ellis WG, Zarow C et al (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59:931–945PubMed
Zurück zum Zitat Vlassenko AG, Vaishnavi SN, Couture L et al (2010) Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc Natl Acad Sci USA 107:17763–17767PubMedCentralPubMedCrossRef Vlassenko AG, Vaishnavi SN, Couture L et al (2010) Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc Natl Acad Sci USA 107:17763–17767PubMedCentralPubMedCrossRef
Zurück zum Zitat Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102PubMedCrossRef Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102PubMedCrossRef
Zurück zum Zitat Wolburg H, Noell S, Mack A et al (2009) Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 335:75–96PubMedCrossRef Wolburg H, Noell S, Mack A et al (2009) Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 335:75–96PubMedCrossRef
Zurück zum Zitat Zechariah A, ElAli A, Hagemann N, Jin F, Doeppner TR, Helfrich I, Mies G, Hermann DM (2013) Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells. Arterioscler Thromb Vasc Biol 33:1561–1567PubMedCrossRef Zechariah A, ElAli A, Hagemann N, Jin F, Doeppner TR, Helfrich I, Mies G, Hermann DM (2013) Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells. Arterioscler Thromb Vasc Biol 33:1561–1567PubMedCrossRef
Zurück zum Zitat Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178–201PubMedCrossRef Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178–201PubMedCrossRef
Metadaten
Titel
Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle
verfasst von
A. Popa-Wagner
Ana-Maria Buga
B. Popescu
D. Muresanu
Publikationsdatum
01.08.2015
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe Sonderheft 1/2015
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-013-1129-3

Weitere Artikel der Sonderheft 1/2015

Journal of Neural Transmission 1/2015 Zur Ausgabe

Psychiatry and Preclinical Psychiatric Studies - Review article

The potential of biomarkers in psychiatry: focus on proteomics

Psychiatry and Preclinical Psychiatric Studies - Review article

Novel putative mechanisms to link circadian clocks to healthy aging

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.